CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us

  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Pikeville Medical Center

Allen C. Omo-Ogboi, MD, Laboratory Medical Director

The Laboratory's Central Role in Patient Management

Allen C. Omo-Ogboi

Allen C. Omo-Ogboi

Diagnostic Medicine Authority

When Laboratory Data Drives Clinical Decisions


The clinical laboratory has evolved from a primarily reactive testing service into an essential partner in patient management. In previous decades, laboratories mainly received specimens, produced results, and returned them to clinicians with minimal context.


Currently, we play an active role in shaping diagnostic pathways, guiding therapy selection, monitoring treatment response, and supporting health initiatives. Laboratory data now influence approximately 70 percent of clinical decisions, placing us at the center of accurate diagnosis, risk stratification, and personalized care.


Building Stronger Bridges Between Labs and Clinicians


Multiple factors, such as multidisciplinary case conferences, embedded laboratory liaisons, and real-time consultation pathways, enable pathologists and laboratory scientists to discuss complex results directly with clinical teams. Shared access to electronic health records, collaboratively developed standardized order sets, and proactive result interpretation including critical value protocols and interpretive comments reduce barriers and foster mutual understanding.


Ongoing educational outreach, including grand rounds, algorithm workshops, and utilization reviews, supports clinicians in ordering appropriate tests and provides laboratory staff with insight into clinical priorities. Trust is strengthened when both parties view the laboratory as a collaborative problem-solving partner.


Technology-Enabled Diagnostics for Better Clinical Decisions


Recent advances in diagnostics and technology have significantly enhanced our role in clinical decision-making. Molecular diagnostics, next-generation sequencing, liquid biopsies, and rapid multiplex PCR now provide actionable information that was previously inaccessible, facilitating targeted therapies and earlier interventions. Properly managed point-of-care testing networks extend high-quality results closer to patients while ensuring standardization.


Trust is strengthened when both parties view the laboratory as a collaborative problem-solving partner.


Advancements in digital pathology have improved laboratory efficiency by converting glass slides into high-resolution digital images using whole-slide scanning. Pathologists can remotely view, annotate, and share these images, eliminating the need for physical transport and expediting consultations and second opinions. Digital archives also reduce storage requirements, minimize the risk of slide loss or damage, and streamline workflows to support higher throughput and enhanced collaboration. These technologies enable us to progress beyond isolated test results and develop integrated diagnostic narratives that inform prognosis, guide therapy selection, and support longitudinal patient monitoring.


Strengthening the Laboratory from Within


Sustaining quality, efficiency, and trust necessitates intentional strategies. Rigorous compliance with accreditation standards, ongoing quality improvement cycles, and comprehensive proficiency testing establish a strong foundation. Lean process redesign, automation of high-volume testing, and data-driven staffing models maintain efficiency without sacrificing accuracy.


Transparent communication of performance metrics, prompt root-cause analysis of errors, and visible leadership commitment to patient safety reinforce trust among clinicians, administrators, and patients. Fostering a culture where every team member recognizes their direct impact on patient outcomes is essential.


Develop a strong foundation in scientific knowledge while also prioritizing communication and systems thinking. Pursue opportunities to engage at the clinical interface, such as participating in tumor boards, antimicrobial stewardship committees, and informatics projects. Attain proficiency in quality systems, data analytics, and healthcare economics to effectively advocate for laboratory resources and appropriate test utilization.


Maintain curiosity about the entire patient journey, as the most impactful laboratory professionals translate complex results into actionable clinical insights. Commit to continuous learning, recognizing that technology and medicine are rapidly evolving. The laboratory’s influence on patient outcomes will continue to expand, and those who combine technical expertise with collaborative leadership will shape the future of healthcare.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

Diagnostic insight carries greater weight when laboratory evidence is connected thoughtfully to the realities of patient care and complex clinical decision-making. For life sciences professionals, this perspective reinforces the value of disciplined interpretation and cross-specialty understanding when uncommon conditions challenge familiar diagnostic assumptions.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreviewapac.com/leadership-perspective/allen-c-omo-ogboi-nwid-3651.html